XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 23, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Line Items]          
Expected dividend yield   0.00%      
Cash funding received from Illumina   $ 1,244,300 $ 304,000    
Illumina, Inc.          
Cash and Cash Equivalents [Line Items]          
Deferred capitalized R&D       $ 447,200  
Domestic Tax Jurisdiction          
Cash and Cash Equivalents [Line Items]          
Net operating loss carryforwards         $ 3,500,000
State Jurisdiction          
Cash and Cash Equivalents [Line Items]          
Net operating loss carryforwards         2,300,000
Customer Concentration Risk | Revenue Benchmark | One Customer          
Cash and Cash Equivalents [Line Items]          
Concentration risk, percentage 10.00% 10.00% 10.00%    
Customer Concentration Risk | Accounts Receivable | One Customer          
Cash and Cash Equivalents [Line Items]          
Concentration risk, percentage 19.00% 43.00%      
Money Market Funds          
Cash and Cash Equivalents [Line Items]          
Cash equivalents in money market accounts $ 955,900 $ 955,900     $ 92,600